Source link : https://yourblogdomain.com/2025/09/23/among-il-1-inhibitors-for-treating-vexas-this-one-stands-out/
Source link : https://newshealth.biz/health-news/among-il-1-inhibitors-for-treating-vexas-this-one-stands-out/ (MedPage Today) — Canakinumab (Ilaris) may be the better option than anakinra (Kineret) when treating the rare disease called VEXAS syndrome with an interleukin-1 (IL-1) inhibitor, a multinational study indicated. Among 47 VEXAS patients treated… Source link : https://www.medpagetoday.com/rheumatology/generalrheumatology/117612 Author : Publish date : 2025-09-23 21:29:00 Copyright for syndicated content belongs […]
—-
Author : yourblogdomain
Publish date : 2025-09-23 23:13:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
Categories